April 26, 2018 | Houston Texas
Clinical Trials Xpress (CTX), an initiative of the University of Texas System, has been named by PAREXEL, the world's leading innovator of biopharmaceutical services, as a member of its Global Site Alliance Network. Through the network, CTX will work with PAREXEL to further clinical development of novel drug therapies through the facilitation of research.
A single point-of-entry for industry sponsors and physician investigators to access streamlined, efficient administrative processes, dedicated central office resources and accelerated activation timelines to conduct their multi-site clinical trials in Texas.
NEWS AND EVENTS
Clinical Trials Xpress (CTX) is a UT System initiative launched in 2015 with support and seed funding from its Board of Regents, CTX represents an unmatched resource to support multisite clinical and translational research in Texas.